Effects of itraconazole and cyclosporine on the pharmacokinetics of sparsentan in healthy male volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Sparsentan (Primary) ; Itraconazole
- Indications Focal segmental glomerulosclerosis
- Focus Pharmacokinetics
- 01 Sep 2017 Results assessing potential effects of itraconazole and cyclosporine on sparsentan pharmacokinetics in healthy male volunteers, were published in the Clinical Pharmacology in Drug Development Conference: 2017 Annual Meeting of the American College of Clinical Pharmacology, ACCP 2017.
- 01 Sep 2017 New trial record